Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
medical-devices: Archive
Envista (NVST) Q1 Earnings Miss Estimates, Margins Down
by Zacks Equity Research
Envista (NVST) registers a year-over-year decline in both segments in the first quarter of 2024.
BSXPositive Net Change ALGNPositive Net Change RMDPositive Net Change NVSTNegative Net Change
earnings medical medical-devices
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
by Zacks Equity Research
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
BSXPositive Net Change DGXPositive Net Change ALGNPositive Net Change RMDPositive Net Change
medical medical-devices
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
by Zacks Equity Research
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change CAHNegative Net Change
earnings medical medical-devices
Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
by Zacks Equity Research
Baxter (BAX) reports better-than-expected first-quarter earnings and sales. BAX's quarterly results reflect solid demand for a range of its medically essential products.
BSXPositive Net Change ECLPositive Net Change BAXPositive Net Change ALGNPositive Net Change
earnings medical medical-devices
BD (BDX) Q2 Earnings Surpass Estimates, FY24 View Revised
by Zacks Equity Research
BD's (BDX) overall top line benefits from revenue growth in all segments and both geographic regions in the fiscal second quarter.
BSXPositive Net Change BDXPositive Net Change ALGNPositive Net Change RMDPositive Net Change
earnings medical medical-devices
Accuray (ARAY) Q3 Earnings Lag Estimates, Gross Margin Contracts
by Zacks Equity Research
Despite strength in radiation oncology, Accuray (ARAY) reports dismal third-quarter fiscal 2024 results.
BSXPositive Net Change ARAYPositive Net Change ALGNPositive Net Change RMDPositive Net Change
earnings medical medical-devices
Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Glaukos' (GKOS) first-quarter 2024 results showcase growth in revenues while earnings miss the Zacks consensus Estimate. Loss at the operating level raises concern as well.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change GKOSPositive Net Change
earnings medical medical-devices
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
by Zacks Equity Research
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
DGXPositive Net Change RMDPositive Net Change HCAPositive Net Change MEDPPositive Net Change
medical medical-devices
Here's Why You Should Retain STERIS (STE) Stock for Now
by Zacks Equity Research
STERIS' (STE) strong prospects in the healthcare and pharmaceutical industries bode well for investors.
BSXPositive Net Change HCAPositive Net Change STENegative Net Change INSPPositive Net Change
medical medical-devices
Top Research Reports for Thermo Fisher Scientific, Walt Disney & Southern Copper
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Thermo Fisher Scientific Inc. (TMO), The Walt Disney Company (DIS) and Southern Copper Corporation (SCCO).
PEGPositive Net Change OMCPositive Net Change TMOPositive Net Change TSCOPositive Net Change DISNegative Net Change SCCONegative Net Change
consumer-discretionary medical-devices
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings
by Zacks Equity Research
Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the first quarter.
DVAPositive Net Change BPMCPositive Net Change GRTSNegative Net Change ERASPositive Net Change
earnings medical medical-devices
Merit Medical (MMSI) Q1 Earnings Top Estimates, Margins Up
by Zacks Equity Research
Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter.
BSXPositive Net Change ALGNPositive Net Change RMDPositive Net Change MMSIPositive Net Change
earnings medical medical-devices
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
by Zacks Equity Research
Here is a sneak peek into how five medical device stocks, BDX, BAX, XRAY, CAH and DVA, might fare in their quarterly results slated to be released tomorrow.
BDXPositive Net Change BAXPositive Net Change DVAPositive Net Change CAHNegative Net Change XRAYPositive Net Change
medical medical-devices
CVS Health's (CVS) Q1 Earnings Miss Estimates, Margins Up
by Zacks Equity Research
CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.
BSXPositive Net Change ALGNPositive Net Change RMDPositive Net Change CVSPositive Net Change
earnings medical medical-devices
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Organon's (OGN) first-quarter results are likely to reflect growth in its biosimilars and established brand franchises with lighter fertility product sales amid foreign exchange headwinds.
BPMCPositive Net Change NVCRPositive Net Change SIBNPositive Net Change OGNPositive Net Change
medical medical-devices
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
by Zacks Equity Research
Inari Medical's (NARI) first-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the companies continue to incur operating losses.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change NARIPositive Net Change
earnings medical medical-devices
IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
by Zacks Equity Research
IDEXX (IDXX) delivers better-than-expected earnings in the first quarter of 2024.
BSXPositive Net Change IDXXPositive Net Change MEDPPositive Net Change EHCPositive Net Change
earnings medical medical-devices
Stryker's (SYK) Q1 Earnings Beat Estimates, Guidance Raised
by Zacks Equity Research
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments and geographies. Operating and gross margins increase, with earnings and revenues beating their respective estimates.
BSXPositive Net Change SYKPositive Net Change ALGNPositive Net Change MEDPPositive Net Change
earnings medical medical-devices
What's in Store for These 4 Medical Device Stocks in Q1 Earnings?
by Indrajit Bandyopadhyay
Here is a sneak peek into how the four medical device stocks, COR, GKOS, ARAY and SRDX, might fare in their quarterly results slated to be release tomorrow.
ARAYPositive Net Change SRDXPositive Net Change CORNegative Net Change GKOSPositive Net Change
medical medical-devices
Cencora (COR) Q2 Earnings Top Estimates, 2024 View Raised
by Zacks Equity Research
Cencora's (COR) second-quarter fiscal 2024 results benefit from overall market growth, including rising demand for GLP-1 drugs and COVID-19 vaccines. Inflationary pressure remains.
BSXPositive Net Change ALGNPositive Net Change CORNegative Net Change MEDPPositive Net Change
earnings medical medical-devices
Stock Market News for May 1, 2024
by Zacks Equity Research
U.S. stock markets tumbled Tuesday, closing sharply lower.
GEHCPositive Net Change
medical-devices
Here's Why You Should Hold Lantheus (LNTH) in Your Portfolio Now
by Zacks Equity Research
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
ECLPositive Net Change BDXPositive Net Change ALGNPositive Net Change LNTHPositive Net Change
medical medical-devices
GE HealthCare (GEHC) Q1 Earnings In Line, Sales Volume Decline
by Zacks Equity Research
GE HealthCare's (GEHC) first-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
ECLPositive Net Change BDXPositive Net Change ALGNPositive Net Change GEHCPositive Net Change
earnings medical medical-devices
Ecolab (ECL) Q1 Earnings Surpass Estimates, Margins Rise
by Zacks Equity Research
Ecolab's (ECL) robust performance across the majority of its segments drives its first-quarter sales despite business challenges.
BSXPositive Net Change ECLPositive Net Change ALGNPositive Net Change DXCMPositive Net Change
earnings medical medical-devices
QIAGEN (QGEN) Q1 Earnings Top Estimates, Margins Expand
by Zacks Equity Research
QIAGEN (QGEN) Q1 results are driven by solid growth in consumables and ongoing higher instruments placements.
BSXPositive Net Change ALGNPositive Net Change DXCMPositive Net Change QGENPositive Net Change
earnings medical medical-devices